Gaviscon Dual
Gaviscon Dual is a medicine authorised by Swissmedic under authorisation number 67374. The authorisation holder is Reckitt Benckiser (Switzerland) AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 22 January 2021 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 67374 |
|---|---|
| Name | Gaviscon Dual |
| Full name | Gaviscon Dual, Kautabletten |
| Authorisation holder | Reckitt Benckiser (Switzerland) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 22 January 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gaviscon Dual, Kautabletten | D | 22 January 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Gaviscon Dual authorised in Switzerland?
Yes. Gaviscon Dual is authorised by Swissmedic under authorisation number 67374, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gaviscon Dual have?
Gaviscon Dual is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Gaviscon Dual?
The authorisation holder is Reckitt Benckiser (Switzerland) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.